Sanofi swaps executives with Bayer in revamp that reshapes diabetes, spotlights China
admin 13th September 2018 Uncategorised 0You might have witnessed some asset swaps in the biopharma industry. But what about executive swaps? Now, Sanofi is exchanging top executives with Bayer as it pushes ahead with a restructuring plan that consolidates the diabetes and cardiovascular market and highlights China.
More: Sanofi swaps executives with Bayer in revamp that reshapes diabetes, spotlights China
Source: fierce